内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Friedman Paul A, 董事. Director active across 3 companies, notably ALEXION PHARMACEUTICALS, INC.. Aggregated, 16 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €422k. History available since 20 May 2021. The latest transaction was filed on 9 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Friedman Paul A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
280 股@ US$15.800.1% 占其流量Common StockSEC:0001628280-26-001981:0
24,520 股@ US$15.809.9% 占其流量Common StockSEC:0001628280-26-001976:0
24,800 股@ US$15.8011.1% 占其流量Common StockSEC:0001628280-25-056794:0
129,172 股@ US$9.4538.7% 占其流量Common StockSEC:0001236927-25-000007:0
3,203 股@ US$9.451.0% 占其流量Common StockSEC:0001236927-25-000005:0
1,400 股@ US$9.450.8% 占其流量Common StockSEC:0001628280-25-035580:0
1,400 股@ US$350.031429.9% 占其流量Common StockSEC:0001628280-25-035580:1
26,176 股@ US$9.4513.1% 占其流量Common StockSEC:0001628280-25-035342:0
715 股0Common StockSEC:0001628280-25-032846:0
714 股0Common StockSEC:0000950170-24-078748:0
26,270 股@ US$9.4516.2% 占其流量Common StockSEC:0000950170-24-043502:0
27,407 股@ US$9.4517.0% 占其流量Common StockSEC:0000899243-24-000265:0
2,254 股@ US$243.9236.1% 占其流量Common StockSEC:0000950170-24-005297:0
26,668 股0Common StockSEC:0000899243-23-002095:0
12,840 股0Common Stock, par value $.0001 per shareSEC:0000899866-21-000075:0
1,962 股0Common Stock, par value $.0001 per shareSEC:0000899866-21-000046:0
About Friedman Paul A
Paul A. Friedman is a Director at Madrigal Pharmaceuticals, INC. and ALEXION PHARMACEUTICALS, INC. He has 16 filings in total, and among the recent filings covered, transactions run from 2021-05-24 to 2026-01-13, with EUR 421889 in sales and a modal transaction nature of Option exercise.